Making A Mark In Materials Science
An Interview With In Vivo Rising Leader Jun Chen
As the leader of UCLA’s Wearable Bioelectronics Research Group, Jun Chen, assistant professor and one of In Vivo’s 2021 Rising Leaders, is deploying sensors, energy-hosting tiles, smart textiles and other technologies to tackle big problems, from health care to sustainable energy.
You may also be interested in...
Venture capitalists and industry executives discussed strategies for placing smart bets on emerging gene therapy companies during a recent virtual panel.
In conjunction with In Vivo’s Rising Leaders series, a panel of senior executives representing a wide spectrum of the life sciences industry – from large biopharmaceuticals to small biotech and cancer diagnostics – was convened to discuss what it takes to successfully lead during times of uncertainty and upheaval. Insights on communication strategies, navigating team integrations, supporting diversity and inclusion, and getting the most from multi-generational employees rested on a common theme: valuing people and anticipating workforce needs.
Expanding partnerships with CROs, the COVID-19 lockdown, an eager FDA and an industry desire for faster and more diverse clinical trial recruiting helped Science 37, a decentralized clinical trial company, nail down plans to go public. Science 37 CEO David Coman spoke with In Vivo about the reasons for going public via SPAC, and why decentralization is a “prerequisite to operating a clinical trial today.”